Stock Events

Medpace 

M$6,890
-M$765-9.99% Friday 15:19

Estadísticas

Día Alto
6,890
Día de baja
6,890
52W Alto
7,655
52W Bajo
4,158
Volumen
0
Volumen medio
0
Cap. de mercado
133.17B
Relación P/U
33.63
Rentabilidad por dividendo
-
Dividendo
-

Próximamente

Ganancias

21OctEsperado
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q3 2024
1.8
2.27
2.73
3.2
GPA esperado
2.770639
GPA actual
3.01

La gente también sigue a

Esta lista se basa en las watchlists de personas que siguen a MEDP.MX en Stock Events. Esto no es una recomendación de inversión.

Competidores

Esta lista es un análisis basado en eventos recientes del mercado. No es una recomendación de inversión.

Acerca de

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Show more...
Director general
Dr. August James Troendle M.D.
Empleados
5000
País
United States
ISIN
US58506Q1094

Listados